¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glycoprotein adenoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® adenoma ÇÑ±Û »ùÁ¾
¼³¸í   
  ºÐºñ»ùÀÇ ¼¼Æ÷¿¡¼­ ±â¿øÇϴ ÀüÀÌ(´Ù¸¥ Á¶Á÷À¸·Î Á÷Á¢ ¶Ç´Â Ç÷¾×À̳ª ¸²ÇÁ¸¦ µû¶ó ÆìÁ®³ª°¡´Â °Í)µÇÁö ¾Ê´Â Á¾¾ç, ¶Ç´Â »óÇǼ¼Æ÷ÀÇ Á¾¾ç Áß¿¡¼­ ºÐºñ»ùÀÇ ¸ð¾çÀ» ÀÌ·ç´Â ¾ç¼º(ÀüÀ̵ÇÁö ¾Ê´Â) Á¾¾ç.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹éÁú
  • variant surface glycoprotein
    »óÀÌÇ¥¸é´ç´Ü¹éÁú
  • apocrine adenoma
    ¾ÆÆ÷Å©¸°»ùÁ¾
  • acidophilic adenoma
    È£»ê¼º»ùÁ¾
  • adenoma
    »ùÁ¾, ¼±Á¾
  • adenoma sebaceum
    ÇÇÁö¼±Á¾, ÇǺα⸧»ùÁ¾
  • adenoma-carcinoma sequence
    »ùÁ¾¾ÏÁ¾¿¬¼â, ¼±Á¾¾ÏÁ¾¿¬¼â
  • adrenal adenoma
    ºÎ½Å»ùÁ¾
  • alveolar adenoma
    ²Ê¸®»ùÁ¾
  • basal cell adenoma
    ¹Ù´Ú¼¼Æ÷»ùÁ¾, ±âÀú¼¼Æ÷¼±Á¾
  • basophilic adenoma
    È£¿°±â»ùÁ¾
  • eccrine papillary adenoma
    ¿¡Å©¸°À¯µÎ»ùÁ¾
  • eosinophil adenoma
    È£»ê»ùÁ¾
  • gastric adenoma
    À§»ùÁ¾
  • hepatic adenoma
    °£»ùÁ¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹éÁú
  • adenoma
    »ùÁ¾
  • gastric adenoma
    À§»ùÁ¾
  • nipple adenoma
    Á¥²ÀÁö»ùÁ¾
  • sebaceous adenoma
    ÇÇÁö»ùÁ¾, ÇǺα⸧»ùÁ¾
  • villous adenoma
    À¶¸ð»ùÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹éÁú
  • variant surface glycoprotein
    »óÀÌÇ¥¸é´ç´Ü¹éÁú
  • adenoma
    »ùÁ¾
  • adenoma sebaceum
    ÇÇÁö»ùÁ¾, ÇǺα⸧»ùÁ¾
  • acidophilic adenoma
    È£»ê»ùÁ¾
  • adenoma-carcinoma sequence
    »ùÁ¾¾ÏÁ¾¼ø¼­
  • adrenal adenoma
    ºÎ½Å»ùÁ¾
  • alveolar adenoma
    ²Ê¸®»ùÁ¾
  • apocrine adenoma
    ¾ÆÆ÷Å©¸°»ùÁ¾
  • basal cell adenoma
    ±âÀú¼¼Æ÷»ùÁ¾, ¹Ù´Ú¼¼Æ÷¾ÏÁ¾
  • basophilic adenoma
    È£¿°±â»ùÁ¾
  • eccrine papillary adenoma
    ¿¡Å©¸°À¯µÎ»ùÁ¾
  • eosinophil adenoma
    È£»ê»ùÁ¾
  • hepatic adenoma
    °£»ùÁ¾
  • islet cell adenoma
    ¼¶¼¼Æ÷»ùÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Glycoprotein hormones, ligands
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)È£¸£¸ó, ¸®°£µå
  • alpha1-acid glycoprotein
    ¾ËÆÄ-»ê´ç´Ü¹é
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ).
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • platelet glycoprotein
    Ç÷¼ÒÆÇ´ç´Ü¹é
  • Leydig cell adenoma
    ·¹À̵ðÈ÷¼¼Æ÷¼±Á¾
  • acidophilic adenoma
    È£»ê¼º¼±Á¾
  • adenoma
    ¼±Á¾(àÍðþ)
  • adenoma sebaceum
    ÇÇÁö¼±Á¾(ù«ò·àÍðþ)
  • adenoma,corticotropin-secreting
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñ¼º(¡­ÝÂÝôàõ)
  • adenoma,gastric polypoid
    À§ Æú¸³¸ð¾ç(êÓ¡­Ù¼åÆ)
  • adenoma,pleomorphic
    ´ÙÇü¼º(Òýû¡àõ, Òýû¡÷¾
  • adenoma,tubular
    °ü»ó(ηßÒ)
  • adenoma,tubulovillous
    °ü-À¶¸ð¼º(η-ëÖÙ¾àõ)
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â(àÍðþ-äßðþ ææáð)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • a-glycoprotein
  • alpha1-acid glycoprotein
    ¾ËÆÄ-»ê´ç´Ü¹é
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ).
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • membrane glycoprotein
    ¸·´ç´Ü¹é
  • platelet glycoprotein
    Ç÷¼ÒÆÇ´ç´Ü¹é
  • surface glycoprotein
    Ç¥¸é´ç´Ü¹é(Áú)(øúØüÓØÓ±ÛÜ)
  • acidophilic adenoma
    È£»ê¼º¼±Á¾
  • adenoma
    ¼±Á¾(àÍðþ)
  • adenoma sebaceum
    ÇÇÁö¼±Á¾(ù«ò·àÍðþ)
  • adenoma,corticotropin-secreting
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñ¼º(¡­ÝÂÝôàõ)
  • adenoma,gastric polypoid
    À§ Æú¸³¸ð¾ç(êÓ¡­Ù¼åÆ)
  • adenoma,pleomorphic
    ´ÙÇü¼º(Òýû¡àõ, Òýû¡÷¾
  • adenoma,tubular
    °ü»ó(ηßÒ)
  • adenoma,tubulovillous
    °ü-À¶¸ð¼º(η-ëÖÙ¾àõ)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variable surface glycoprotein (VSG)
    º¯À̼ºÇ¥¸é´ç´Ü¹éÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenoma
    ¼±Á¾(àÍðþ)
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • Tamm-Horsfall glycoprotein
    Ž-È£¸£½ºÆú ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹éÁú
  • adenoma
    ¼±Á¾
  • adenoma sebaceum
    ÇÇÁö¼±Á¾
  • chromophobe adenoma
    Çø»ö¼Ò¼º ¼±Á¾
  • islet cell adenoma
    Ãéµµ¼¼Æ÷¼±Á¾
  • malignant adenoma
    ¾Ç¼º¼±Á¾
  • pituitary adenoma
    ³úÇϼöü¼±Á¾
  • pleomorphic adenoma
    ´ÙÇü¼º¼±Á¾
  • sebaceous adenoma
    ÇÇÁö¼±Á¾
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
SGP serine glycerophosphatide; sialoglycoprotein; Society of General Physiologists; soluble glycoprotein...
APA action potential amplitude; aldosterone-producing adenoma; Ambulatory Pediatric Association; America...
DAA decompensated autonomous adenoma; dementia associated with alcoholism; dialysis-associated amyloidos...
HA H antigen; Hakim-Adams [syndrome]; halothane anesthesia; Hartley [guinea pig]; headache; health alli...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
APA Aldosterone Producing Adenoma
dra Down Regulated in Adenoma
HA Hepatic Adenoma
PA Pleomorphic Adenoma
TA Toxic adenoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acidophilic adenoma
    »êÈ£¼º ¼±Á¾, È£»ê¼º ¼¼Æ÷ ¼±Á¾, È£»ê¼º ¼±Á¾
    1. º¸Åë ³úÇϼöü Àü¿±¿¡¼­ º¸´Â Á¾¾çÀ¸·Î¼­ ±× ¼¼Æ÷°¡ »ê¼º »ö¼Ò¿¡ ¿°»öµÈ´Ù. 2. ´ÜÇü ¼±Á¾À¸·Î ÀÌÇϼ±, Çù Á¡¸·, ¿©¼º¿¡°Ô È£¹ßÇÑ´Ù.
  • adenoma
    ¼±Á¾
    ¼± Á¶Á÷°ú °°Àº ±¸Á¶¹°À» °¡Áö´Â ¾ç¼º »óÇÇ Á¾¾ç. ¼¼Æ÷°¡ ¼± ¸ð¾çÀÇ ±¸Á¶¸¦ Çü¼ºÇϵ簡 ¶Ç´Â ¼¼Æ÷°¡ È®½ÇÈ÷ ¼± »óÇÇ¿¡¼­ »ý°Ü³µ´Ù°í »ý°¢µÇ´Â ¾ç¼ºÀÇ »óÇǼº Á¾¾ç.
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â
  • alveolar adenoma
    Æ÷»ó ¼±Á¾
  • ameloblastic adenoma
    ¹ý¶û¾Æ¼¼Æ÷ ¼±Á¾
  • apocrine adenoma
    ¾ÆÆ÷Å©¸° ¼±Á¾
  • bile duct adenoma
    ´ã°ü ¼±Á¾
    ȸ¹é»öÀÇ ´Ü´ÜÇÑ ÀÛÀº °áÀý·Î ºÎ°Ë´ë¿¡¼­ ¿ì¿¬È÷ ¹ß°ßµÇ¸ç 1cmÀ» ³Ñ´Â °æ¿ì°¡ µå¹°´Ù. Á¶Á÷ÇÐÀûÀ¸·Î´Â ´ã°ü°ú °°Àº »óÇǹ迭¼º ÆÇ»ó ±¸Á¶µéÀÌ ºñ±³Àû dzºÎÇÑ °áüÁ¶Á÷¼º °£Áú·Î ºÐ¸®µÇ¾î ÀÖ´Ù. ÇǸ·Àº ´ëºÎºÐÀÇ °æ¿ì¿¡ ¾øÀ¸¸ç ´ãÁó¼º Âø»öÀº ¾ø´Ù. ÀÌ Á¾¾çÀÇ ¼º»óÀº ¿À´Ã³¯ °ú¿ÀÁ¾À¸·Î ¹Ï¾îÁö°í ÀÖÀ¸¸ç ¼±Ãµ¼º ±¹¼Ò ´ã°ü¼º Áõ½Ä º´º¯ÀÎ Æù¿¡ÀÌ¿£¹ö±× º¹ÇÕü
  • breast lactating adenoma
    À¯¹æ À¯¼±Á¾
  • canalicular adenoma
    ´ÜÇü ¼±Á¾
    ¼Ò Ÿ¾×¼±ÀÇ Á¾¾ç, ¹«Áõ»óÀÌ¸ç ¿Ï¸¸ÇÑ Áõ½Ä°ú ÁøÇàÀ» º¸ÀÌ´Â °æ°è°¡ ¸íÈ®ÇÑ µüµüÇÑ °áÀý.
  • chromophobe adenoma
    Çø»ö¼Ò¼º ¼±Á¾
  • corticotropin-secreting adenoma
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñ¼º ¼±Á¾
  • cystic adenoma
    ³¶»ó ¼±Á¾
  • eccrine papillary adenoma
    ¿¡Å©¸° À¯µÎ»ó ¼±Á¾
  • eosinophil adenoma
    È£»ê¼º ¼±Á¾
  • huthle cell adenoma
    ÈÖ¸£Æ®·¹ ¼¼Æ÷ ¼±Á¾, Huthle ¼¼Æ÷ ¼±Á¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
a1-acid glycoprotein <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases.
(18 Nov 1997)
acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase <enzyme> Forms oligosaccharide core class 3 (glcnac beta 1-3galnac) in mucins and various glycoproteins
Registry number: EC 2.4.1.147
Synonym: udp-glcnac-galnac-r beta 3-acetylglucosaminyltransferase, agggag-transferase
(26 Jun 1999)
amyloidogenic glycoprotein <protein> An integral membrane glycoprotein of the brain and related to the Drosophila vnd gene product. A precursor of _ amyloid, that accumulates in Alzheimer's disease and Down's syndrome.
See: amyloid precursor protein.
(18 Nov 1997)
b2-glycoprotein II <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase.
Registry number: EC 3.4.21.47
(12 Dec 1998)
beta-1,3-galactosyl-0-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase <enzyme> Capable of adding a glcnac residue to g1cnacman(3)g1cnac; from mung bean seedlings
Registry number: EC 2.4.1.146
Synonym: n-acetylglucosaminyltransferase II, gal3-(glcnac6)galnac-mucin (glcnac--gal)3-glcnactransferase
(26 Jun 1999)
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferase <enzyme> With EC 2.4.1.148 this is called beta6-glcnac-transferase b
Registry number: EC 2.4.1.102
Synonym: gal3-galnac-mucin-6-glcnac transferase, udp-glcnac-gal1-3galnac-r-(glcnac to galnac)-beta1-6glcnac transferase, core 2 glcnac transferase, core 2-n-acetylglucosaminyltransferase, core 2 beta6-gn-t
(26 Jun 1999)
beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase <enzyme> Induced in preneoplastic stage of liver carcinogenesis promoted by orotic acid in rats; adds "bisecting n-acetylglucosaminyl residue in beta 1,4 linkage to the beta-linked mannose of the core of asparagine-linked oligosaccharides
Registry number: EC 2.4.1.144
Synonym: n-acetylglucosaminyltransferase III, udpgnac-glycopeptide beta4-n-acetylglucosaminyl transferase III, udpgnac-magtransferase III, udp-n-acetylglucosamine-beta-d-mannoside beta-1,4-n-acetylglucosaminyltransferase III
(26 Jun 1999)
carbohydrate-deficient glycoprotein syndrome <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors.
(12 Dec 1998)
variable surface glycoprotein <protein> One of a battery of antigenicdeterminants expressed by a microorganism to elude immune detection.
(09 Oct 1997)
mannosyl-glycoprotein endo-beta-n-acetylglucosaminidase <enzyme> A group of related enzymes responsible for the endohydrolysis of the di-n-acetylchitobiosyl unit in high-mannose-content glycopeptides and glycoproteins.
Chemical name: Glycopeptide-D-mannosyl-N(4)-(N-acetyl-D-glucosaminyl)2-asparagine 1,4-N-acetyl-beta-glucosaminohydrolase
Registry number: EC 3.2.1.96
(12 Dec 1998)
glycine-rich beta-glycoprotein <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase.
Registry number: EC 3.4.21.47
(12 Dec 1998)
glycoprotein <protein> Proteins with covalently attached sugar units, either bonded via the OH group of serine or threonine O glycosylated) or through the amide NH2 of asparagine (N glycosylated).
Includes most secreted proteins (serum albumin is the major exception) and proteins exposed at the outer surface of the plasma membrane. Sugar residues found include: mannose, N acetyl glucosamine, N acetyl galactosamine, galactose, fucose and sialic acid.
(18 Nov 1997)
glycoprotein endo-alpha-1,3-mannosidase <enzyme> An endomannosidase; cleaves glucosyl alpha1-3-mannose from monoglucosylated oligosaccharide (glcman(7-9)glcnac) of the glycoprotein produced in the golgi membrane
Registry number: EC 3.2.1.130
Synonym: glucosyl mannosidase
(26 Jun 1999)
glycoprotein glycosyltransferase <enzyme> Enzymes which add monosaccharides from nucleoside mono-or diphosphate monosaccharides onto glycoproteins
Registry number: EC 2.4.1.-
(26 Jun 1999)
glycoprotein hormones, alpha subunit A non-covalently bound subunit of the glycoprotein hormones tsh, fsh, lh, and hcg which originates in the anterior pituitary gland and placenta. This subunit is virtually identical in structure and indistinguishable by radioimmunoassay in all of the above glycoproteins. It is present in both men and women, but is elevated in postmenopausal women and in patients with hypothyroidism, uraemia and malignant tumours. The alpha subunit may be involved directly in recognition of certain receptors.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenoma
    ¼±Á¾
  • glycoprotein
    ´ç´Ü¹é(Áú)(Á¡¾×¼Ò ¹× ¿¬°ñÀÇ ÁÖ¼ººÐ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á